Pier 88 Investment Partners LLC Pyxis Oncology, Inc. Transaction History
Pier 88 Investment Partners LLC
- $77.7 Million
- Q3 2025
A detailed history of Pier 88 Investment Partners LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 151,730 shares of PYXS stock, worth $540,158. This represents 0.42% of its overall portfolio holdings.
Number of Shares
151,730
Previous 367,170
58.68%
Holding current value
$540,158
Previous $403,000
18.11%
% of portfolio
0.42%
Previous 0.47%
Shares
7 transactions
Others Institutions Holding PYXS
# of Institutions
71Shares Held
22.5MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$12.9 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$12.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$9.92 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$8.9 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$7.65 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $125M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...